Toshiba America Medical Systems has debuted four multifrequency transducers to expand its flagship PowerVision ultrasound scanner's pelvic, vascular, and transcranial capabilities. The Tustin, CA-based vendor also released SmartTrace, a spectral Doppler
Toshiba America Medical Systems has debuted four multifrequency transducers to expand its flagship PowerVision ultrasound scanner's pelvic, vascular, and transcranial capabilities. The Tustin, CA-based vendor also released SmartTrace, a spectral Doppler quantification mode for vascular and abdominal studies.
The newest additions to Toshiba's line of probes are two endocavity transducers, a linear-array transducer for peripheral vascular and small-parts exams, and a phased-array sector transducer for transcranial applications. For endocavity imaging, the vendor's PVK-651VT transducer offers an extended 150 field-of-view, which allows physicians to distinguish between intrauterine and ectopic pregnancies, as well as to detect fetal abnormalities, according to the company. The vendor's PVK-720ST transducer, on the other hand, helps physicians to anatomically and hemodynamically evaluate the prostate gland and pelvic cavity with a 120 field-of-view, according to Toshiba.
In vascular and small-parts applications, PLK-503AT supports routine screening and imaging for examining palpable and nonpalpable lesions, including adenomas, fluid collections, and cysts, according to the company. The PSK-20CT phased-array transducer is targeted for the evaluation of intracranial stenosis, occlusions, and several other transcranial applications.
With the company's SmartTrace technique, the Doppler waveform is automatically traced, eliminating the need for manual manipulation, according to the company. The technique, particularly suitable for vascular and abdominal studies, leads to ultrasound exams that are more quantitative, less subjective, and easier to perform, said Suzanne Certain, director of ultrasound marketing.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
GE HealthCare Unveils Enhanced LesionID Pro at SNMMI Conference
Published: June 21st 2025 | Updated: June 21st 2025Emphasizing a zero-click experience, the updated LesionID Pro software, to be introduced at the SNMMI conference, reportedly provides AI-powered automated insights into whole-body tumor burden with PET and SPECT imaging.
Can CT-Based Deep Learning Bolster Prognostic Assessments of Ground-Glass Nodules?
June 19th 2025Emerging research shows that a multiple time-series deep learning model assessment of CT images provides 20 percent higher sensitivity than a delta radiomic model and 56 percent higher sensitivity than a clinical model for prognostic evaluation of ground-glass nodules.